The transcription factor Wilms' tumor 1 (WT1) is one of the best characterised and most highly immunogenic tumor‐associated antigens (TAAs) and is an excellent target for therapeutic cancer vaccines.6 The gene discussed is WT1; the disease is neoplasm.